RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/15789339http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/15789339http://www.w3.org/2000/01/rdf-schema#comment"The CX3C chemokine fractalkine (CX3CL1) exists as both a membrane-bound form promoting firm cell-cell adhesion and a soluble form chemoattracting leukocytes expressing its receptor CX3CR1. When adenoviral vector expressing mouse fractalkine (AdFKN) was transduced to the tumor cells, fractalkine was expressed as both membrane-bound form on the tumor cells and soluble form in the supernatant in vitro. Intratumoral injection of AdFKN (1 x 10(9)PFU/tumor) into C26 and B16F10 tumors resulted in marked reduction of tumor growth compared to control (C26: 86.5%, p<0.001; B16F10: 85.5%, p<0.001). Histological examination of tumor tissues revealed abundant infiltration of NK cells, dendritic cells, and CD8(+) T lymphocytes 3 and/or 6 days after treatment with AdFKN. Splenocytes from mice treated by AdFKN developed tumor-specific cytotoxic T cells, and thereby protected from rechallenging with parental tumor cells. Antitumor effects by AdFKN were completely abrogated in both NK cell-depleted mice and CD8(-/-) mice, and partially blocked in CD4(-/-) mice. These data indicated that fractalkine mediates antitumor effects by both NK cell-dependent and T cell-dependent mechanisms. This study suggests that fractalkine can be a suitable candidate for immunogene therapy of cancer because fractalkine induces both innate and adaptive immunity."xsd:string
http://purl.uniprot.org/citations/15789339http://purl.org/dc/terms/identifier"doi:10.1002/eji.200526042"xsd:string
http://purl.uniprot.org/citations/15789339http://purl.uniprot.org/core/author"Hagiwara K."xsd:string
http://purl.uniprot.org/citations/15789339http://purl.uniprot.org/core/author"Kikuchi T."xsd:string
http://purl.uniprot.org/citations/15789339http://purl.uniprot.org/core/author"Suzuki T."xsd:string
http://purl.uniprot.org/citations/15789339http://purl.uniprot.org/core/author"Ohkouchi S."xsd:string
http://purl.uniprot.org/citations/15789339http://purl.uniprot.org/core/author"Honjo T."xsd:string
http://purl.uniprot.org/citations/15789339http://purl.uniprot.org/core/author"Nukiwa T."xsd:string
http://purl.uniprot.org/citations/15789339http://purl.uniprot.org/core/author"Xin H."xsd:string
http://purl.uniprot.org/citations/15789339http://purl.uniprot.org/core/author"Saijo Y."xsd:string
http://purl.uniprot.org/citations/15789339http://purl.uniprot.org/core/author"Huqun"xsd:string
http://purl.uniprot.org/citations/15789339http://purl.uniprot.org/core/author"Andarini S."xsd:string
http://purl.uniprot.org/citations/15789339http://purl.uniprot.org/core/date"2005"xsd:gYear
http://purl.uniprot.org/citations/15789339http://purl.uniprot.org/core/name"Eur J Immunol"xsd:string
http://purl.uniprot.org/citations/15789339http://purl.uniprot.org/core/pages"1371-1380"xsd:string
http://purl.uniprot.org/citations/15789339http://purl.uniprot.org/core/title"Antitumor immune response by CX3CL1 fractalkine gene transfer depends on both NK and T cells."xsd:string
http://purl.uniprot.org/citations/15789339http://purl.uniprot.org/core/volume"35"xsd:string
http://purl.uniprot.org/citations/15789339http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/15789339
http://purl.uniprot.org/citations/15789339http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/15789339
http://purl.uniprot.org/uniprot/#_P70443-mappedCitation-15789339http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/15789339
http://purl.uniprot.org/uniprot/#_P06332-mappedCitation-15789339http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/15789339
http://purl.uniprot.org/uniprot/#_P01731-mappedCitation-15789339http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/15789339
http://purl.uniprot.org/uniprot/#_O55054-mappedCitation-15789339http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/15789339
http://purl.uniprot.org/uniprot/#_Q8CAX3-mappedCitation-15789339http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/15789339